We demonstrate that glutamate stress signature genes have the strongest enrichment across all MS and EAE datasets and identify the regulatory network of the MS risk–associated inhibitory GRM8 to be robustly enriched in neurons of MS patients. The gene discussed is GRM8; the disease is myeloid sarcoma.